Broncano-Lavado Antonio, Senhaji-Kacha Abrar, Santamaría-Corral Guillermo, Esteban Jaime, García-Quintanilla Meritxell
Department of Clinical Microbiology, IIS-Fundación Jiménez Díaz, Av. Reyes Católicos, 2, 28040 Madrid, Spain.
CIBERINFEC-Infectious Diseases CIBER, Madrid, Spain.
Antibiotics (Basel). 2022 Sep 28;11(10):1322. doi: 10.3390/antibiotics11101322.
complex is extremely difficult to treat. Intrinsic and acquired bacterial resistance makes this species one of the most challenging pathogens and treatments last from months to years, associated with potential risky antibiotic toxicity and a high number of failures. Nonantibiotic antimicrobial agents against this microorganism have recently been studied so as to offer an alternative to current drugs. This review summarizes recent research on different strategies such as host modulation using stem cells, photodynamic therapy, antibiofilm therapy, phage therapy, nanoparticles, vaccines and antimicrobial peptides against both in vitro and in vivo.
该复合体极难治疗。内在和获得性细菌耐药性使该物种成为最具挑战性的病原体之一，治疗持续数月至数年，伴有潜在的危险抗生素毒性和大量治疗失败情况。最近对针对这种微生物的非抗生素抗菌剂进行了研究，以便为现有药物提供替代方案。本综述总结了最近关于不同策略的研究，如使用干细胞进行宿主调节、光动力疗法、抗生物膜疗法、噬菌体疗法、纳米颗粒、疫苗和抗菌肽，包括体外和体内研究。
